申请人:ALIGOS THERAPEUTICS INC
公开号:WO2022081758A1
公开(公告)日:2022-04-21
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
本文提供了公式(I)的化合物,或其药学上可接受的盐,包括描述此处化合物(包括其药学上可接受的盐)的药物组合物和合成它们的方法。此外,本文还提供了使用公式(I)的化合物或其药学上可接受的盐治疗疾病和/或病症的方法。